Global NK Cell Therapy Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033

According to DIResearch＇s in-depth investigation and research, the global NK Cell Therapy market size will reach 659.69 Million USD in 2026 and is projected to reach 2,111.42 Million USD by 2033, with a CAGR of 18.08% (2026-2033). Notably, the China NK Cell Therapy market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

NK cell therapy, or Natural Killer cell therapy, is an emerging form of immunotherapy that harnesses the body＇s own immune system to combat cancer and other diseases. Natural Killer (NK) cells are a type of immune cell that plays a crucial role in detecting and destroying abnormal or infected cells, including cancer cells. NK cell therapy involves the isolation and expansion of these specialized immune cells from a patient＇s own body or a donor source and their subsequent infusion into the patient. The expanded NK cells are engineered or activated to enhance their ability to recognize and target cancer cells more effectively. NK cell therapy has shown promise in various cancer treatments, providing a targeted and potent immunotherapeutic approach that can work alongside or in conjunction with other cancer therapies to combat the disease and improve patient outcomes.

The major global suppliers of NK Cell Therapy include Nektar Therapeutics, Innate Pharma, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of NK Cell Therapy. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global NK Cell Therapy market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the NK Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of NK Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of NK Cell Therapy Include:

Nektar Therapeutics

Innate Pharma

Affimed

Chipscreen Biosciences

Fate Therapeutics

Glycostem Therapeutics

Dragonfly Therapeutics

Kiadis Pharma

NantWorks

Nkarta Therapeutics

Fortress Biotech

NK Cell Therapy Product Segment Include:

NK Cell Therapies

NK Cell Directed Antibodies

NK Cell Therapy Product Application Include:

Cancer

Gastrointestinal Diseases

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global NK Cell Therapy Industry PESTEL Analysis

Chapter 3: Global NK Cell Therapy Industry Porter's Five Forces Analysis

Chapter 4: Global NK Cell Therapy Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global NK Cell Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global NK Cell Therapy Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, NK Cell Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources

Table 1： NK Cell Therapy Industry Development Status

Table 2： NK Cell Therapy Industry Development Trends

Table 3： Global NK Cell Therapy Revenue and Growth Rate (CAGR) by Country: 2025 VS 2026 VS 2033 (US$ Million)

Table 4： Global NK Cell Therapy Revenue by Country (2021-2026) & (US$ Million)

Table 5： Global NK Cell Therapy Revenue Market Share by Country (2021-2026)

Table 6： Global NK Cell Therapy Revenue Forecast by Country (2027-2033) & (US$ Million)

Table 7： Global NK Cell Therapy Revenue Market Share Forecast by Country (2027-2033)

Table 8： Global NK Cell Therapy Market Revenue by Key Suppliers (2021-2026) & (US$ Million)

Table 9： Global NK Cell Therapy Revenue Market Share by Key Suppliers (2021-2026)

Table 10： Global Key Suppliers Headquarter and Key Area Sales

Table 11： Market Mergers & Acquisitions, Expansion

Table 12： Global NK Cell Therapy Market Size and Growth Rate (CAGR) Analysis by Type: 2025 VS 2026 VS 2033 (US$ Million)

Table 13： Global NK Cell Therapy Revenue Analysis by Type (2021-2026) & (US$ Million)

Table 14： Global NK Cell Therapy Revenue Forecast Analysis by Type (2027-2033) & (US$ Million)

Table 15： Nektar Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 16： Nektar Therapeutics NK Cell Therapy Product Portfolio

Table 17： Nektar Therapeutics NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 18： Innate Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 19： Innate Pharma NK Cell Therapy Product Portfolio

Table 20： Innate Pharma NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 21： Affimed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 22： Affimed NK Cell Therapy Product Portfolio

Table 23： Affimed NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 24： Chipscreen Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 25： Chipscreen Biosciences NK Cell Therapy Product Portfolio

Table 26： Chipscreen Biosciences NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 27： Fate Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 28： Fate Therapeutics NK Cell Therapy Product Portfolio

Table 29： Fate Therapeutics NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 30： Glycostem Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 31： Glycostem Therapeutics NK Cell Therapy Product Portfolio

Table 32： Glycostem Therapeutics NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 33： Dragonfly Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 34： Dragonfly Therapeutics NK Cell Therapy Product Portfolio

Table 35： Dragonfly Therapeutics NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 36： Kiadis Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 37： Kiadis Pharma NK Cell Therapy Product Portfolio

Table 38： Kiadis Pharma NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 39： NantWorks Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 40： NantWorks NK Cell Therapy Product Portfolio

Table 41： NantWorks NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 42： Nkarta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 43： Nkarta Therapeutics NK Cell Therapy Product Portfolio

Table 44： Nkarta Therapeutics NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 45： Fortress Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 46： Fortress Biotech NK Cell Therapy Product Portfolio

Table 47： Fortress Biotech NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 48： Global NK Cell Therapy Market Size and Growth Rate (CAGR) by Application: 2025 VS 2026 VS 2033 & (US$ Million)

Table 49： Global NK Cell Therapy Revenue Analysis by Application (2021-2026) & (US$ Million)

Table 50： Global NK Cell Therapy Revenue Forecast Analysis by Application (2027-2033) & (US$ Million)

Table 51： NK Cell Therapy Typical Customer List

Table 52： NK Cell Therapy Distributors List

Figure 1： NK Cell Therapy Product Pictures

Figure 2： NK Cell Therapies Picture Scope

Figure 3： NK Cell Directed Antibodies Picture Scope

Figure 4： Cancer Picture Scope

Figure 5： Gastrointestinal Diseases Picture Scope

Figure 6： Others Picture Scope

Figure 7： Global NK Cell Therapy Market Size Analysis：2025 VS 2026 VS 2033 (US$ Million)

Figure 8： Global NK Cell Therapy Market Revenue and Growth Rate Analysis: (2021-2033) & (US$ Million)

Figure 9： Global NK Cell Therapy Revenue Market Share by Country in 2025

Figure 10： United States NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 11： Germany NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 12： Japan NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 13： China NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 14： France NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 15： U.K. NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 16： South Korea NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 17： Canada NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 18： Italy NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 19： Russia NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 20： Mexico NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 21： Brazil NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 22： India NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 23： Vietnam NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 24： Thailand NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 25： South Africa NK Cell Therapy Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 26： Global NK Cell Therapy Revenue Market Share by Key Suppliers in 2025

Figure 27： Global NK Cell Therapy Industry Competition Landscape

Figure 28： Global NK Cell Therapy Market Size by Type (2021-2033) (US$ Million)

Figure 29： Global NK Cell Therapy Market Share by Type: 2026 & 2033

Figure 30： NK Cell Therapy Industry Chain Analysis

Figure 31： Global NK Cell Therapy Revenue Market Share by Application (2021-2033)

Figure 32： Key Interview Objectives

Figure 33： Bottom-Up and Top-Down Research Methods